Proathlete Wealth Management »

Biogen Idec shares owned by Proathlete Wealth Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Proathlete Wealth Management from 13F filings

Historical chart of Proathlete Wealth Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Proathlete Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Proathlete Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $413k 1.9k 215.63
2023-12-31 $498k 1.9k 258.77

More positions owned by Proathlete Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Cohen Steer Reit (ICF)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Proathlete Wealth Management

Top funds holding Biogen Idec

PRIMECAP Management Company
Vanguard Group
Wellington Management Company
Jpmorgan Chase & Co
Van Eck Associates Corp.
ClearBridge Advisors
Legal & General Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Dimensional Fund Advisors
Amundi
Deutsche Bank Aktiengesellschaft
Susquehanna International
Goldman Sachs Group

View all funds holding Biogen Idec